Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib and Selenomethionine in Advanced Metastatic Clear Cell Renal Cell Carcinoma
NCT02535533Phase 2Completed
- Start
- Jan 2016
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selenomethionine in clear cell renal cell carcinoma (ccRCC). Started Jan 2016; status: completed.
02
Drugs
selenomethionine
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT02535533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02535533.